LABELING CHANGE CANNABINOIDS DOUBLE ANTI. IN URINE
K-Number: K873753 · 1987-10-15
Advertisement
Device Summary
Frequently Asked Questions
What is the LABELING CHANGE CANNABINOIDS DOUBLE ANTI. IN URINE?
LABELING CHANGE CANNABINOIDS DOUBLE ANTI. IN URINE is a medical device that received FDA 510(k) clearance on 1987-10-15. The listed applicant is Diagnostic Products Corp.. The 510(k) number is K873753.
When did LABELING CHANGE CANNABINOIDS DOUBLE ANTI. IN URINE receive FDA 510(k) clearance?
LABELING CHANGE CANNABINOIDS DOUBLE ANTI. IN URINE received FDA 510(k) clearance on 1987-10-15, under 510(k) number K873753.
Who is the listed applicant for LABELING CHANGE CANNABINOIDS DOUBLE ANTI. IN URINE?
The FDA 510(k) record lists Diagnostic Products Corp. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for LABELING CHANGE CANNABINOIDS DOUBLE ANTI. IN URINE?
The FDA product code for LABELING CHANGE CANNABINOIDS DOUBLE ANTI. IN URINE is LDJ.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Diagnostic Products Corp. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: LDJ)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement